Osteoporosis diagnosis and medical treatment.

Osteoporosis, the presence of either low bone mineral density or a history of a fragility fracture, is known to be associated with an increased risk of future fracture. Fracture prevention is possible through use of both nonpharmacologic and prescription treatments. Despite recent controversy regarding the safety of calcium supplementation and the appropriate dosing of calcium and vitamin D, calcium and vitamin D remain an important part of bone health. However, prescription osteoporosis treatments should be considered for those at higher risk for fracture, and there are currently several treatment options available.

[1]  S. Cummings,et al.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.

[2]  S B Roberts,et al.  Exercise training and nutritional supplementation for physical frailty in very elderly people. , 1994, The New England journal of medicine.

[3]  L. Gillespie,et al.  Hip protectors for preventing hip fractures in older people. , 2010, The Cochrane database of systematic reviews.

[4]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[5]  D. Kiel,et al.  A Higher Dose of Vitamin D Reduces the Risk of Falls in Nursing Home Residents: A Randomized, Multiple‐Dose Study , 2007, Journal of the American Geriatrics Society.

[6]  Claus Christiansen,et al.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis. , 2009, The New England journal of medicine.

[7]  D. Kiel,et al.  Efficacy of a Hip Protector to Prevent Hip Fracture in Nursing Home Residents The HIP PRO Randomized Controlled Trial , 2007 .

[8]  G. Guyatt,et al.  VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women , 2002 .

[9]  C. Deal,et al.  Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis. , 2003, Cleveland Clinic journal of medicine.

[10]  C. Christiansen,et al.  Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study , 2004, Osteoporosis International.

[11]  R. Harwood,et al.  A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. , 2004, Age and ageing.

[12]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.

[13]  J. Pasco,et al.  The Exclusion of High Trauma Fractures May Underestimate the Prevalence of Bone Fragility Fractures in the Community: The Geelong Osteoporosis Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  S. Cummings,et al.  Continuing bisphosphonate treatment for osteoporosis--for whom and for how long? , 2012, The New England journal of medicine.

[15]  J. Eisman,et al.  Risk of subsequent fracture after low-trauma fracture in men and women. , 2007, JAMA.

[16]  Hideyo Yoshida,et al.  Randomized controlled trial of exercise intervention for the prevention of falls in community-dwelling elderly Japanese women , 2004, Journal of Bone and Mineral Metabolism.

[17]  S. Gabriel,et al.  Forearm Fractures as Predictors of Subsequent Osteoporotic Fractures , 1999, Osteoporosis International.

[18]  D. Felsenberg,et al.  Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study , 1999, Osteoporosis International.

[19]  U. P. S. T. Force,et al.  Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement , 2011, Annals of Internal Medicine.

[20]  U. Lindgren,et al.  Trauma type, age, and gender as determinants of hip fracture , 1987, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[21]  K. Kita,et al.  A simple protocol for preventing falls and fractures in elderly individuals with musculoskeletal disease , 2007, Osteoporosis International.

[22]  R. Newcombe,et al.  Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation , 2007, Osteoporosis International.

[23]  W. O'Fallon,et al.  Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  D. Bauer,et al.  Physical Activity and Osteoporotic Fracture Risk in Older Women , 1998, Annals of Internal Medicine.

[25]  P. Tugwell,et al.  Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. , 2024, The Cochrane database of systematic reviews.

[26]  L. Mosekilde,et al.  Vitamin D and Calcium Supplementation Prevents Osteoporotic Fractures in Elderly Community Dwelling Residents: A Pragmatic Population‐Based 3‐Year Intervention Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  J A Stevens,et al.  Reducing falls and resulting hip fractures among older women. , 2000, Home care provider.

[28]  M. Tinetti,et al.  The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. , 1995, JAMA.

[29]  W C Hayes,et al.  Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. , 1998, The American journal of medicine.

[30]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[31]  G. Guyatt,et al.  Meta-Analyses of Therapies for Postmenopausal Osteoporosis , 2002 .

[32]  Bess Dawson-Hughes,et al.  Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[33]  François Duboeuf,et al.  Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women , 1992 .

[34]  O. Johnell,et al.  FRAX™ and the assessment of fracture probability in men and women from the UK , 2008, Osteoporosis International.

[35]  Richard L Prince,et al.  Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. , 2006, Archives of internal medicine.

[36]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[37]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[38]  S. Boonen,et al.  Zoledronic acid and clinical fractures and mortality after hip fracture. , 2007, The New England journal of medicine.

[39]  J. Hopper,et al.  Serum Vitamin D and Falls in Older Women in Residential Care in Australia , 2003, Journal of the American Geriatrics Society.

[40]  S. Cummings,et al.  High-trauma fractures and low bone mineral density in older women and men. , 2007, JAMA.

[41]  C Ronald MacKenzie,et al.  Hip fractures among the elderly: causes, consequences and control , 2003, Ageing Research Reviews.

[42]  Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy , 2005 .

[43]  P. Klentrou,et al.  Longitudinal evaluation of supervised versus unsupervised exercise programs for the treatment of osteoporosis , 2000, European Journal of Applied Physiology.

[44]  A. C. Laing,et al.  Effect of soft shell hip protectors on pressure distribution to the hip during sideways falls , 2008, Osteoporosis International.

[45]  E. Harju,et al.  Annual injection of vitamin D and fractures of aged bones , 1992, Calcified Tissue International.

[46]  M. A. Hansen,et al.  Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. , 1992, BMJ.

[47]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[48]  R. Lew,et al.  Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  J Dequeker,et al.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.

[50]  H. Bischoff-Ferrari,et al.  Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. , 2006, Archives of internal medicine.

[51]  C. Cooper,et al.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial , 2005, The Lancet.

[52]  A. LaCroix,et al.  Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  Colin R Dunstan,et al.  A Single‐Dose Placebo‐Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  W. Willett,et al.  A pooled analysis of vitamin D dose requirements for fracture prevention. , 2012, The New England journal of medicine.

[55]  J. Manson,et al.  Calcium Intake and Risk of Cardiovascular Disease , 2012, American Journal of Cardiovascular Drugs.

[56]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[57]  J. Gertner,et al.  25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol. , 1977, Journal of clinical pathology.

[58]  V. Moyer.  Prevention of Falls in Community-Dwelling Older Adults: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[59]  C. Christiansen,et al.  Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[60]  P. Ebeling.  Osteoporosis in men , 1999, Current opinion in rheumatology.

[61]  H K Genant,et al.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. , 1999, JAMA.

[62]  J. Hopper,et al.  Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trial , 2005, Journal of the American Geriatrics Society.

[63]  M. Karlsson,et al.  Individuals who sustain nonosteoporotic fractures continue to also sustain fragility fractures , 1993, Calcified Tissue International.

[64]  A. Avenell,et al.  Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis , 2011, BMJ : British Medical Journal.

[65]  Marcea Whitaker,et al.  Bisphosphonates for osteoporosis--where do we go from here? , 2012, The New England journal of medicine.

[66]  C C Glüer,et al.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. , 1999, JAMA.

[67]  I. Reid,et al.  Randomized controlled trial of calcium in healthy older women. , 2006, The American journal of medicine.

[68]  L. Bouter,et al.  Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.

[69]  P. Barber,et al.  Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial , 2008, BMJ : British Medical Journal.

[70]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[71]  R. Eastell,et al.  Osteoporosis in men: an Endocrine Society clinical practice guideline. , 2012, The Journal of clinical endocrinology and metabolism.

[72]  A. Avenell,et al.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis , 2010, BMJ : British Medical Journal.

[73]  A. Tosteson,et al.  Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.